Bimekizumab
Monoclonal antibody used in the treatment of psoriasis
| Bimekizumab | |
|---|---|
| File:Bimekizumab.png | |
| INN | |
| Drug class | |
| Routes of administration | Subcutaneous |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | Rx-only |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Bimekizumab is a monoclonal antibody used in the treatment of psoriasis and other inflammatory conditions. It is marketed under the trade name Bimzelx. Bimekizumab works by selectively inhibiting the activity of interleukin-17A (IL-17A) and interleukin-17F (IL-17F), which are cytokines involved in inflammatory processes.
Mechanism of Action[edit | edit source]
Bimekizumab is a biologic therapy that targets and neutralizes IL-17A and IL-17F. These cytokines are part of the interleukin-17 family, which plays a crucial role in the pathogenesis of autoimmune diseases such as psoriasis. By inhibiting these cytokines, bimekizumab reduces inflammation and the symptoms associated with psoriasis.
Clinical Use[edit | edit source]
Bimekizumab is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is administered via subcutaneous injection.
Administration[edit | edit source]
The recommended dosage of bimekizumab is an initial dose followed by maintenance doses at regular intervals. The specific dosing schedule may vary based on the patient's response and the prescribing physician's recommendations.
Side Effects[edit | edit source]
Common side effects of bimekizumab include upper respiratory tract infections, headache, and injection site reactions. Serious side effects may include increased risk of infections, such as tuberculosis, and hypersensitivity reactions.
Contraindications[edit | edit source]
Bimekizumab is contraindicated in patients with known hypersensitivity to the drug or any of its components. It should be used with caution in patients with a history of chronic infections or those who are immunocompromised.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
